Related Experiment Video
Updated: Mar 3, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Statins and pancreatic cancer
Jun Gong1, Esha Sachdev2, Lori A Robbins2
1Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Statins may help prevent pancreatic cancer and improve survival, particularly in patients with metabolic syndrome. Research explores their antitumor mechanisms, including inhibiting key signaling pathways and lipid metabolism crucial for pancreatic ductal adenocarcinoma (PDAC) growth.
Area of Science:
- Oncology
- Pharmacology
- Cancer Prevention
Background:
- Pancreatic cancer is a highly lethal malignancy with limited treatment options.
- Metabolic syndrome components (diabetes, obesity, dyslipidemia) are recognized modifiable risk factors.
- Statins show potential in reducing pancreatic cancer risk and improving survival.
Purpose of the Study:
- To review current evidence on statins as chemopreventive agents for pancreatic cancer.
- To discuss the elucidated antitumor mechanisms of statins in pancreatic cancer.
Main Methods:
- Review of preclinical studies (in vitro, in vivo) on statins and pancreatic cancer.
- Analysis of proposed molecular mechanisms of statin action.
- Examination of epidemiological data regarding statin use and pancreatic cancer risk/survival.
Main Results:
- Statins demonstrate antitumor effects in pancreatic cancer cell lines and animal models.
- Preclinical data suggest statins delay pancreatic intraepithelial neoplasia progression and inhibit PDAC formation.
- Proposed mechanisms involve inhibiting the mevalonate pathway, Ras/MAPK signaling, PI3K/Akt pathway, and modulating lipid metabolism and inflammation.
Conclusions:
- Statins hold promise as a chemopreventive strategy for pancreatic cancer.
- Understanding statin's antitumor mechanisms can guide future therapeutic development.
- Further research is warranted to confirm clinical efficacy and optimize statin use in pancreatic cancer prevention and treatment.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Psychoneuroimmunology: Diabetes and Cancer
Acute Pancreatitis II: Clinical Manifestations and Management

